Argon Medical Devices is latest US health firm to get dose of Chinese funds
New York
SHANDONG Weigao Group Medical Polymer Co agreed to buy closely held Argon Medical Devices Inc for US$850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the US healthcare market.
Shandong Weigao made the acquisition through a joint venture with a private equity-backed firm that will control 10 per cent, according to a statement to the Hong Kong stock exchange. The venture will fund US$420 million of the purchase with debt, the company said without identifying the private-equity firm.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue